Stem cell news is always burbling up, sometimes right there in front of us on the web and other times via networks of people. Astellas news. Some may remember there used to be this pioneering stem cell biotech called ACT, which then became Ocata, and finally was acquired by the big company Astellas. One of […]
Stem cell news bites: Astellas trial, cystic fibrosis claim, a few cool papers Read More »
For me there was a sense of “finally” when just under 3 months ago the FDA filed suits via the DOJ against 2 stem cell clinic firms, U.S. Stem Cell (and its affiliate U.S. Stem Cell Clinic, collectively referred to here as USRM) and California Stem Cell Treatment Center/Cell Surgical Network (collectively referred to here as
As 2 FDA stem cell clinic suits slowly unfold, more action needed now Read More »
What do you get when celebrity podcaster Joe Rogan talks about stem cells? There can be big impact one way or another. I don’t believe his shows on stem cells have helped provide solid info. What do I mean? Patients can be strongly influenced by what they see on social media and YouTube videos pack
Deconstructing Joe Rogan promotional stem cell video with Mel Gibson Read More »
It’s an odd confluence of events this week that (A) the Nuffield Council, an ethics think tank, gives a thumbs up in a new report to heritable human genetic modification that would probably include using CRISPR in the same week that (B) a new paper reports that CRISPR can cause unpredictable genomic damage and several other concerning reports
Mixed Nuffield Council Report Too Aspirational on Human Genetic Modification Read More »
Heritable CRISPR to be tried in humans sooner or later…or never? Will someone somewhere in the world try to use CRISPR gene editing or related technology to introduce heritable genetic changes into actual human beings in the next decade? I’m not talking about gene editing viable human embryos just for research which is already ongoing,
Poll: heritable CRISPR tried in humans in next 10 years? Read More »
Every year in December I go out onto a limb and make stem cell predictions for the coming year as I did in late 2017 for this year. Then usually around the 1/2-way point through the year I check in on how the predictions are faring so far at that point. In this post I give
Midterm grades on my 20 x 2018 stem cell predictions Read More »
One of the highlights of Day 1 of #ISSCR2018 for me so far was the talk by Lorenz Studer (Co-Founder of BlueRock) on the use of human embryonic stem cell (HESC)-derived dopamine neurons for Parkinson’s Disease. Note that for this post and if I have time any others on this meeting, they are probably going
Lorenz Studer on Day 1 #ISSCR2018: HESC-based therapies for Parkinson’s Disease Read More »
Ain’t nothing like the real thing…right? No, by the ‘real thing’ I’m not talking about Coke versus Pepsi or Coke versus Diet Coke, but rather stem cells. (On a side note there’s still some people who apparently believe the stem cell myth that there are stem cells in Pepsi). I get a regular stream of
Stem-ish cells: what’s the real thing? Read More »
By Anna Everette The title of this article is partially borrowed from a fascinating Lightning Presentation delivered by John Doench of Broad Institute at CRISPRcon this year. In his talk, Mr. Doench pointed out how we’ve been looking up to this promising technology for a while now, hoping it will deliver the anticipated results (see
The Hope of CRISPRcon: Year 2, Guest Post by Anna Everette Read More »
The world is constantly bombarded these days with often-hyped stories of the latest celebrities who got unproven stem cells, including most recently Jack Nicklaus and now Tarek El Moussa of Flip or Flop TV real estate fame. Both these celebs got stem cells for orthopedic kind of health situations, but while in theory stem cells
Tarek El Moussa stem cell shot, a flip or a flop? Risks of celeb buzz Read More »